Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Nanoparticle transport across the blood brain barrier.
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Opinion: Sex inclusion in basic research drives discovery.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Biologics-induced autoimmune diseases.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Flupirtine
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Pages
« first
‹ previous
…
55
56
57
58
59
60
61
62
63
…
next ›
last »